Loading…
Hosted by Parexel · 🇺🇸 US · EN · 18 episodes
Established thought leaders with verified media credentials.
Clinical Trialblazers invites you into the world of biotech leaders as they share the untold stories behind their journeys to bring breakthrough innovations to life. This 10 episode monthly series asks biotech visionaries to explore pivotal moments in their careers and the milestones that shaped their lives. Through unscripted conversations, host Alberto Grignolo dives into the decisions, risks, and accomplishments that define these trialblazers legacies to uncover the heart, grit, and ingenuity driving the future of scientific innovation.
Parexel hosts Clinical Trialblazers, a science show with 18 episodes published.
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Briggs Morrison, CEO of Crossbow Therapeutics and former Chief Medical Officer and Head of Global Medicines Development at AstraZeneca. B
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Reenie McCarthy, the CEO of Mighty Therapeutics, formerly known as Stealth BioTherapeutics. Reenie shares her path from venture investor to b
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Joe von Rickenbach, co-founder of Parexel and a pioneer of the modern clinical research organization (CRO) industry, to discuss his journey f
How do you go from lawyer to biotech CEO? In this episode of Clinical Trialblazers, Heather Turner, CEO of LB Pharmaceuticals, shares her journey from legal counsel to leading a late-stage biotech company. She discusses
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Allison Jeynes, CEO of Nefro Avillion Clinical Development, to explore her remarkable journey from clinician to biotech leader. With over
Clinical Trialblazers is back for Season Two. Host Alberto Grignolo speaks with Paul Garofolo, Co-Founder and CEO of Locus Biosciences, about the leadership mindset behind capital efficiency, resource prioritization, and
Clinical Trialblazers will be back soon! Season 2 will bring together a dynamic mix of biotech innovators, executives, and industry leaders to reveal the strategy and teamwork fueling the next wave of clinical breakthrou
In this season finale of Clinical Trialblazers, host Alberto Grignolo reflects on key insights and themes from conversations with biotech leaders over the past year. From researchers to entrepreneurs to investors, Albert
In this episode of Clinical Trialblazers, Alberto sits down with Dr. Geeta Vemuri, Founder and Managing Partner of Agent Capital. They discuss Dr. Vemuri’s journey into venture capital, offering valuable insights on what
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Miquel Vila-Perello, Ph.D. co-founder and CEO of SpliceBio, a gene therapy company focused on treating Stargardt disease. They discuss Miquel
In this episode of Clinical Trialblazers, Lyla Bibi, Partner at Goldman Sachs and Head of Healthcare Equity Capital Markets, shares her impactful career journey focused on helping bring cutting-edge therapies to life by
In this episode of Clinical Trialblazers, Dr. Antti Vuolanto, CEO of Herantis Pharma Plc, shares his unconventional journey into the biotech industry, from bioengineering to leading a company focused on central nervous s
In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Dr. Ross Breckenridge, CEO of Arjuna Therapeutics, a company pioneering a novel approach to precision oncology through therapeutic molecular clu
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Sam Blackman, co-founder and former Chief Medical Officer of Day One Biopharmaceuticals, board member of the Pediatric Brain Tumor Founda
In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Kerrie Brady, Chairperson of Neurocentrx Pharmaceuticals and an Independent Board Member at Asklepion Pharmaceuticals and Invea Therapeutics. Ke
In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on m
In this episode of Clinical Trialblazers, Michael Bailey, President and CEO of Aveo Oncology, shares his insights on the evolving landscape of oncology trials and their impact on patient care. Join host Alberto Grignolo
Step inside the world of biotech leaders as they share the untold stories behind their journeys to bring breakthrough innovations to patients. Each episode uncovers the heart, grit, and ingenuity of the people shaping th
Heather Turner
CEO and Co-Founder · Tamarack Capital Partners
1 appearance on this show
Michael Bailey
Director of Open Architecture Studio in Brisbane · The Fortress of Baileytude Podcasting Network
1 appearance on this show
Reenie McCarthy
Mighty Therapeutics
1 appearance on this show
Joe von Rickenbach
Parexel
1 appearance on this show
Dr. Allison Jeynes
Nefro Avillion Clinical Development
1 appearance on this show
Paul Garofolo
Locus Biosciences
1 appearance on this show
Dr. Geeta Vemuri
Agent Capital
1 appearance on this show
Miquel Vila-Perello
SpliceBio
1 appearance on this show
Lyla Bibi
Goldman Sachs
1 appearance on this show
Dr. Antti Vuolanto
Herantis Pharma Plc
1 appearance on this show
Dr. Ross Breckenridge
Arjuna Therapeutics
1 appearance on this show
Robert Blum
Cytokinetics
1 appearance on this show
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Clinical Trialblazers has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
Clinical Trialblazers is hosted by Parexel. The show is categorised under science (life) and has published 18 episodes.
Clinical Trialblazers has published 18 episodes.
Clinical Trialblazers regularly covers science, life, health. It sits in the science category, with a life focus.
Clinical Trialblazers is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Clinical Trialblazers hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Clinical Trialblazers average 29 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Clinical Trialblazers's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 4 days ago.